Apeiron Investment Group Ltd. - Feb 23, 2023 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
10%+ Owner
Signature
Apeiron Investment Group Ltd., By: /s/ Julien Hofer, Director
Stock symbol
SNSE
Transactions as of
Feb 23, 2023
Transactions value $
$3,539
Form type
4
Date filed
2/27/2023, 07:10 PM
Previous filing
Feb 2, 2024
Next filing
Mar 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $1.78K +1.1K +0.04% $1.62 2.48M Feb 23, 2023 By Apeiron Investment Group Ltd. F1, F2
transaction SNSE Common Stock Purchase $1.76K +1.1K +0.04% $1.60 2.49M Feb 23, 2023 By Apeiron Investment Group Ltd. F1, F2
holding SNSE Common Stock 956K Feb 23, 2023 By Presight Sensei Co-Invest Fund, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is filed jointly by Apeiron Investment Group Ltd. ("Apeiron"), Christian Angermayer, Presight Sensei Co-Invest Fund, L.P. ("Presight Co-Invest") and Presight Sensei Co-Invest Management, L.L.C. ("Presight Co-Invest Management", and collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F2 Securities owned directly by Apeiron. Mr. Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities owned directly by Apeiron.
F3 Securities owned directly by Presight Co-Invest. As the general partner of Presight Co-Invest, Presight Co-Invest Management may be deemed to beneficially own the securities owned directly by Presight Co-Invest. As the sole member of Presight Co-Invest Management, Apeiron may be deemed to beneficially own the securities owned directly by Presight Co-Invest. Mr. Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities owned directly by Presight Co-Invest.